Literature DB >> 30914014

Obesity and Body Composition in Man and Woman: Associated Diseases and the New Role of Gut Microbiota.

Ennio Avolio1,2, Paola Gualtieri1, Lorenzo Romano3, Claudio Pecorella2, Simona Ferraro3, Giuseppe Palma4, Laura Di Renzo1, Antonino De Lorenzo1.   

Abstract

BACKGROUND: Obesity is now recognized as a worldwide health issue and has reached epidemic proportions, affecting both developed and developing countries. The World Obesity Federation stated that "Obesity is a chronic relapsing disease process": as a result, obesity has been recognized internationally as a chronic disease. The primary cause of the metabolic syndrome and increase of the cardiovascular risk have been identified in "sick fat", a condition then defined as adiposopathy. Heart attacks, strokes and renal failures are pathologies that have mid-risk factors such as dyslipidemia, hypertension and diabetes, which in turn are caused by obesity, whose primary risk factor is represented by the diet. The aim of the present review is to consider the importance of body composition, together with chronic inflammation and a new gut microbiota data that may turn out to be crucial elements of some target treatment of human obesity.
METHODS: In this review, we performed research using PubMed database reviewing the evidence in the literature of evidence information regarding the link between obesity and body composition in the development of metabolic disease via inflammation markers and in particular, the new role exerted by gut microbiota.
RESULTS: Several papers were evaluated searching for differences in fat mass and disease risk. We also identified the same papers dealing with differences in body composition and metabolic syndrome. Our attention focuses also on a new frontier of gut microbiota composition in the body weight decrease and anti-inflammatory effects.
CONCLUSION: To the saving of lean mass, for the prevention of cardiometabolic diseases, also considering the relationship with obesity, it is necessary to reduce the inflammatory state, acting on the gut-microbiota and on the intestinal permeability. To improve the health of the intestinal flora, we propose a 4P medicine and treatment with probiotics, prebiotics, postbiotics, and polyphenols. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Obesity; adiposopathy; body composition; gut microbiota; inflammation; metabolic disease.

Mesh:

Substances:

Year:  2020        PMID: 30914014     DOI: 10.2174/0929867326666190326113607

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  8 in total

Review 1.  From obesity through gut microbiota to cardiovascular diseases: a dangerous journey.

Authors:  Paolo Marzullo; Laura Di Renzo; Gabriella Pugliese; Martina De Siena; Luigi Barrea; Giovanna Muscogiuri; Annamaria Colao; Silvia Savastano
Journal:  Int J Obes Suppl       Date:  2020-07-20

Review 2.  The athletic gut microbiota.

Authors:  Alex E Mohr; Ralf Jäger; Katie C Carpenter; Chad M Kerksick; Martin Purpura; Jeremy R Townsend; Nicholas P West; Katherine Black; Michael Gleeson; David B Pyne; Shawn D Wells; Shawn M Arent; Richard B Kreider; Bill I Campbell; Laurent Bannock; Jonathan Scheiman; Craig J Wissent; Marco Pane; Douglas S Kalman; Jamie N Pugh; Carmen P Ortega-Santos; Jessica A Ter Haar; Paul J Arciero; Jose Antonio
Journal:  J Int Soc Sports Nutr       Date:  2020-05-12       Impact factor: 5.150

3.  Body Composition Findings by Computed Tomography in SARS-CoV-2 Patients: Increased Risk of Muscle Wasting in Obesity.

Authors:  Paola Gualtieri; Carmela Falcone; Lorenzo Romano; Sebastiano Macheda; Pierpaolo Correale; Pietro Arciello; Nicola Polimeni; Antonino De Lorenzo
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

Review 4.  COVID-19: Is there a role for immunonutrition in obese patient?

Authors:  Laura Di Renzo; Paola Gualtieri; Francesca Pivari; Laura Soldati; Alda Attinà; Claudia Leggeri; Giulia Cinelli; Maria Grazia Tarsitano; Giovanna Caparello; Elena Carrano; Giuseppe Merra; Alberto Maria Pujia; Roberta Danieli; Antonino De Lorenzo
Journal:  J Transl Med       Date:  2020-11-07       Impact factor: 5.531

5.  Application of machine learning in prediction of Chemotherapy resistant of Ovarian Cancer based on Gut Microbiota.

Authors:  Ting-Ting Gong; Xin-Hui He; Song Gao; Qi-Jun Wu
Journal:  J Cancer       Date:  2021-03-15       Impact factor: 4.207

6.  Body mass index is associated with Helicobacter pylori infection and increased oxidative DNA damage in an obese population.

Authors:  Wesam Ahmed Nasif; Mohammed Hasan Mukhtar; Abeer Shaker El-Moursy Ali; Mohamed Mahmoud Nour Eldein; Riyad Adnan Almaimani; Sami Sadagah Ashgar
Journal:  J Int Med Res       Date:  2022-02       Impact factor: 1.671

7.  A Preliminary Study on the Value of Intestinal Flora in Predicting Major Adverse Cardiovascular and Cerebrovascular Events in Patients with Refractory Hypertension.

Authors:  Jie Jiao; Yeping Zhang; Pengda Han; Shuya Zhai
Journal:  Comput Math Methods Med       Date:  2022-08-24       Impact factor: 2.809

Review 8.  Molecular Mechanisms of Obesity-Linked Cardiac Dysfunction: An Up-Date on Current Knowledge.

Authors:  Jorge Gutiérrez-Cuevas; Ana Sandoval-Rodriguez; Alejandra Meza-Rios; Hugo Christian Monroy-Ramírez; Marina Galicia-Moreno; Jesús García-Bañuelos; Arturo Santos; Juan Armendariz-Borunda
Journal:  Cells       Date:  2021-03-12       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.